-- Cadila Healthcare Gets Phase I Trial Permission for Anti-Diabetic Molecule
-- Tuhin Kar
-- 2010-06-21T05:51:25Z
-- http://www.bloomberg.com/news/2010-06-21/cadila-gets-permission-to-start-initial-patient-study-on-diabetes-medicine.html

          
          
             Cadila Healthcare Ltd. received
permission to conduct Phase I clinical trial for ZYOG1, an oral
anti-diabetic molecule, according to a statement today on the
Bombay Stock Exchange.  
          
          


  


        